The Split Hand Index (SHI) compares APB, FDI, and ADM CMAP amplitudes to detect disproportionate lateral hand atrophy - pattern suggestive of ALS. The ADM/APB ratio aids differential diagnosis.
SHI = (APB × FDI) / ADM | ADM/APB (reverse split hand)
Split Hand Index calculator for EMG/NCS: electrophysiological biomarker for amyotrophic lateral sclerosis (ALS), APB vs ADM comparison. For clinical use only.
The Split Hand Index (SHI) compares APB, FDI, and ADM CMAP amplitudes to detect disproportionate lateral hand atrophy - pattern suggestive of ALS. The ADM/APB ratio aids differential diagnosis.
SHI = (APB × FDI) / ADM | ADM/APB (reverse split hand)
The Split-Leg Index (SLI) = EDB/AH - lower-limb analogue of split hand.
SLI = CMAP EDB (fibular) / CMAP AH (tibial)
The Split Hand Index (SHI) = (APB × IOD) / ADM (CMAP in mV). Mean in controls ≈ 9.1; < 5.2 suggests ALS.
| Population | SHI (mean) | Interpretation | Source |
|---|---|---|---|
| Controls | ≈ 9.1 (± 0.3) | Normal | Menon 2013 |
| Possible ALS | ≈ 5.1 (± 0.8) | Investigate | Menon 2013 |
| Definite/probable ALS | ≈ 3.0 (± 0.5) | Suggestive | Menon 2013 |
| Cutoff | < 5.2 | Sens. 74%, Spec. 80–88% | Menon 2013 |
The Split Hand Index (SHI) is calculated as: SHI = (APB CMAP × FDI CMAP) / ADM CMAP, where APB = Abductor Pollicis Brevis (median nerve innervated), FDI = First Dorsal Interosseous (ulnar nerve innervated), and ADM = Abductor Digiti Minimi (ulnar nerve innervated). All Compound Muscle Action Potential (CMAP) amplitudes must be entered in millivolts (mV), reliably reflecting the viability and quantity of functioning motor fibers and axons in the target muscle.
The "split-hand" phenomenon (or split-hand syndrome) is a clinical and electrophysiological finding of extreme relevance in the diagnosis of motor neuron diseases, particularly Amyotrophic Lateral Sclerosis (ALS). The condition refers to the preferential and disproportionate atrophy and weakness of the lateral hand musculature — specifically the abductor pollicis brevis (APB) and first dorsal interosseous (FDI) — compared to the relative preservation of the medial hand musculature, represented by the abductor digiti minimi (ADM). In clinical practice, this sign can often be noticed immediately during the initial handshake with the patient.
Historically, the first observation of this dissociation pattern was published by Andrew Eisen in 1992, who noted more severe impairment of the APB relative to the ADM in ALS. In 1999, Satoshi Kuwabara reinforced this finding, and in 2000, A. J. Wilbourn formally coined the term "split-hand syndrome", including the fundamental observation that the FDI also undergoes preferential atrophy.
The most intriguing aspect of the split-hand phenomenon is that the APB is innervated by the median nerve, while the FDI and ADM are innervated by the ulnar nerve. However, all share the same spinal segment and root origin (C8–T1). Thus, the asymmetry in neurodegeneration deviates from a simple isolated peripheral nerve lesion or radiculopathy pattern. The main proposed pathophysiological mechanisms include:
To translate clinical observation into an objective, quantitative, and reproducible metric, the Split-Hand Index (SHI) was developed from routine motor nerve conduction studies. The main interpretation parameters and cutoffs include:
Although highly specific, a pure split-hand pattern or reduced index values can appear in the clinical setting of other neuroaxial pathologies:
In contrast to the typical presentation described, neurophysiological literature has documented the opposite phenomenon: the Reverse Split-Hand. This condition is evidenced by predominant atrophy and weakness of the medial musculature innervated by lower roots (C8–T1), with the ADM muscle being primarily affected compared to the preservation of the lateral region (APB and FDI).
The gap between symptom onset and definitive diagnosis in ALS can regrettably extend between 10 and 18 months. Transitioning from visual observation of the split-hand to rapid computation of the Split-Hand Index (SHI) in the EMG laboratory increases diagnostic accuracy at an early stage. By providing a reliable biomarker, the index distinguishes ALS from benign mimics, allows earlier patient enrollment in robust clinical trials, and expedites the initiation of targeted disease-modifying therapies to help slow the progression of motor loss.
References:
· Menon P et al. Split-hand index for the diagnosis of amyotrophic lateral sclerosis. Muscle Nerve 2013;47(2):218–223.
· Eisen A et al. Preferential spinal motor neuron loss in amyotrophic lateral sclerosis. J Neurol Sci 1992;113(2):137–143.
· Wilbourn AJ. The "split hand" syndrome. Muscle Nerve 2000;23(1):138.
· Kuwabara S et al. Surface EMG and the split-hand index in ALS. J Neurol 2011;258(7):1383–1385.
· Wijesekera LC et al. Afferent inhibition and split-hand pattern in ALS. Brain 2009;132(Pt 5):1271–1284.
In healthy controls, mean SHI is approximately 9.1 (± 0.3).
SHI below 5.2 (Menon et al., 2013).
Disproportionate atrophy of lateral hand muscles (APB, IOD) with relative ADM preservation, suggestive of lower motor neuron degeneration in ALS.
It is the opposite pattern of the typical split-hand, characterized by predominant atrophy and weakness of the medial muscle (ADM) with preservation of the lateral musculature (APB and FDI). An ADM / APB CMAP ratio < 0.6 corroborates reverse split-hand, which is classically associated with Hirayama disease, cervical spondylotic amyotrophy, and isolated C8 radiculopathies.
Although highly specific for ALS, the pattern can appear in other motor neuron diseases (such as Spinal Muscular Atrophy, Kennedy's disease, and Spinocerebellar Ataxia type 3), hereditary polyneuropathies (especially Charcot-Marie-Tooth disease type 2D - GARS gene), and as a false positive in isolated T1 root lesions or lower trunk brachial plexopathies (which, unlike ALS, present with ulnar sensory conduction abnormalities).
The Split-Leg Index (SLI) = EDB CMAP / AH CMAP. Normal median 0.7 (Choi et al., 2020).
| Population | SLI | Source |
|---|---|---|
| Controls (median) | 0.7 (IQR 0.5–1.0) | Choi 2020 |
| ALS lower limbs | Reduced | Simon 2015 |
Median 0.7 (IQR 0.5–1.0) in controls.